Patent details

EN | LT

LT - Transtiretino (TTR) amiloidozės terapija antikūnų pagrindu ir jai skirti iš žmogaus organizmo gauti antikūnai

EN - ANTIBODY-BASED THERAPY OF TRANSTHYRETIN (TTR) AMYLOIDOSIS AND HUMAN-DERIVED ANTIBODIES THEREFOR

Legal status

Patent in force

Claims | Licences/Sublicenses

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07K 16/18	(2006.01)

European patent
(11)	Number of the document	3083681
(13)	Kind of document	T
(96)	European patent application number	14833579.7
	Date of filing the European patent application	2014-12-22
(97)	Date of publication of the European application	2016-10-26
(45)	Date of publication and mention of the grant of the patent	2020-07-22
(46)	Date of publication of the claims translation	2020-11-25

PCT application
(86)	Number	PCT/EP2014/079094
	Date	2014-12-22

PCT application publication
(87)	Number	WO 2015/092077
	Date	2015-06-25

Priority applications
(30)	Number	Date	Country code
	13199251	2013-12-20	EP

Inventors
(72)	GRIMM, Jan, CH MICHALON, Aubin, CH

Grantee
(73)	Neurimmune Holding AG, Wagistrasse 18, 8952 Schlieren, CH

Attorney or representative
(74)	Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT

Title
(54)	Transtiretino (TTR) amiloidozės terapija antikūnų pagrindu ir jai skirti iš žmogaus organizmo gauti antikūnai
	ANTIBODY-BASED THERAPY OF TRANSTHYRETIN (TTR) AMYLOIDOSIS AND HUMAN-DERIVED ANTIBODIES THEREFOR

Last renewal fee
	Payment date	Validity (years)	Amount
	2025-11-19	12	289.00 EUR

Next renewal fee
	2026-12-22